June 7- News Wise
“We have the opportunity to eliminate multiple HPV-related cancers, beginning with cervical cancer,” said Anna R. Guiliano, PhD, director of the Center for Infection Research in Cancer at Moffitt Cancer Center, who will participate in the Huntsman meeting. She urged health care providers to recommend the HPV vaccine to patients and parents to ask their children’s doctors about it.
June 7- BioPortfolio
"Neuroendocrine tumor progression is often associated with deterioration in quality of life due to tumor growth and production of hormones,," said Jonathan Strosberg, MD, Associate Professor, Section Head, Neuroendocrine Tumor Program at Moffitt Cancer Center, and lead author of the publication.
June 7- Tampa Bay Times online
All proceeds from the event will benefit Moffitt Cancer Center, which is the only National Cancer Institute-designated Comprehensive Cancer Center in Florida and one of only 49 in the United States
June 6- Medical Health News
Use of geriatric assessment in the routine care of older advanced cancer patients improved oncologist-patient communication and started conversations that otherwise would have been ignored, a randomized study found.
June 5- Medical Xpress
For patients at Moffitt Cancer Center, they compared Foundation Medicine results to sequencing results from banked blood samples.
June 5 – BBC 1
The life of a woman with terminal breast cancer has been saved by a pioneering new therapy. We are joined by Dr. Ben Creelan, an immunotherapy expert.
Medical Health News
"The combination of these drugs with ibuprofen could significantly increase the risk for bleeding complications," says David Craig, PharmD, pharmacist lead at the Moffitt Cancer Center, and American Pain Society E-News editor.
Medical Health News
“In the current analysis, higher numbers of new male sexual partners were consistently associated with higher recurrence of incident infections in both type-specific (HPV 16) and grouped analyses,” according to the study investigators led by Anna R. Giuliano, PhD, director of the Center for Infection Research in Cancer at the Moffitt Cancer Center.
Scott Antonia, an immunologist at Moffitt Cancer Center in Tampa, Florida, said further work is crucial. One of them, a 59-year-old woman came to her office recently with a recurrence score of 17, and was seriously considering chemotherapy.
Scott Antonia, an immunologist at Moffitt Cancer Center in Tampa, Florida, said further work is crucial. “The paper shows the biological proof of principle and that you can use this approach to have a profound impact on a patient,” he noted. “We should continue to go down that path.”
For the study, researchers reviewed data from patients with solid tumor cancers who had genetic sequencing tests performed by Foundation Medicine as part of their routine clinical care at the N.C. Cancer Hospital and the Moffitt Cancer Center between 2013 and 2017.
“We are encouraged by the strong long-term complete response rates in ZUMA-1, which represents a patient population that previously had few if any remaining treatment options,” said Frederick L. Locke, MD, ZUMA-1 Co-Lead Investigator and Vice Chair of the Department of Blood and Marrow Transplant and Cellular Immunotherapy at Moffitt Cancer Center in Tampa, Florida.
College Football Talk
Culpepper had been battling cancer with treatment at Moffitt Cancer Center in Tampa while traveling back and forth between Tampa and Syracuse.
Medical Health News
David Sallman, MD, of the malignant hematology department at the Moffitt Cancer Center & Research Institute in Tampa, Florida, said looking at each type of AML separately helps to tailor therapy and better categorize patients as being high risk, intermediate risk, or low risk.
American Journal of Managed Care
At ASCO, Frederick Locke, MD, program coleader, Immunology, Moffitt Cancer Center and Research Institute, presented the longer-term update during an afternoon session.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.